New: Introducing the Finviz Crypto Map

Tevogen Bio Inc

Contributing Author

Recent Articles by Tevogen Bio Inc

Jul-18	Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides TVGN GlobeNewswire
Jul-17	Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility TVGN GlobeNewswire
Jul-16	Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell Alpha Launch TVGN GlobeNewswire
Jul-14	Tevogen.AI Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs TVGN GlobeNewswire
Jul-10	Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation TVGN GlobeNewswire
Jun-30	Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters TVGN GlobeNewswire
Jun-18	Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery TVGN GlobeNewswire
Jun-09	Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives TVGN GlobeNewswire
May-30	Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships TVGN GlobeNewswire
May-23	Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow TVGN GlobeNewswire
May-22	Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting TVGN GlobeNewswire
May-12	Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation TVGN GlobeNewswire
May-02	Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest TVGN GlobeNewswire

Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.